Verrica Pharmaceuticals Inc (VRCA) support and resistance · rev $10.9M
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
This page maps Verrica Pharmaceuticals Inc (VRCA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
VRCA currently screens at market cap $79.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VRCA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VRCA quote page for the session range and the stock page for the full model.
Not investment advice.